4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effects and Mechanisms of Tea for the Prevention and Management of Diabetes Mellitus and Diabetic Complications: An Updated Review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Diabetes mellitus has become a serious and growing public health concern. It has high morbidity and mortality because of its complications, such as diabetic nephropathy, diabetic cardiovascular complication, diabetic neuropathy, diabetic retinopathy, and diabetic hepatopathy. Epidemiological studies revealed that the consumption of tea was inversely associated with the risk of diabetes mellitus and its complications. Experimental studies demonstrated that tea had protective effects against diabetes mellitus and its complications via several possible mechanisms, including enhancing insulin action, ameliorating insulin resistance, activating insulin signaling pathway, protecting islet β-cells, scavenging free radicals, and decreasing inflammation. Moreover, clinical trials also confirmed that tea intervention is effective in patients with diabetes mellitus and its complications. Therefore, in order to highlight the importance of tea in the prevention and management of diabetes mellitus and its complications, this article summarizes and discusses the effects of tea against diabetes mellitus and its complications based on the findings from epidemiological, experimental, and clinical studies, with the special attention paid to the mechanisms of action.

          Related collections

          Most cited references164

          • Record: found
          • Abstract: not found
          • Article: not found

          Diagnosis and Classification of Diabetes Mellitus

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Global estimates of the prevalence of diabetes for 2010 and 2030.

            We estimated the number of people worldwide with diabetes for the years 2010 and 2030. Studies from 91 countries were used to calculate age- and sex-specific diabetes prevalences, which were applied to national population estimates, to determine national diabetes prevalences for all 216 countries for 2010 and 2030. Studies were identified using Medline, and contact with all national and regional International Diabetes Federation offices. Studies were included if diabetes prevalence was assessed using a population-based methodology, and was based on World Health Organization or American Diabetes Association diagnostic criteria for at least three separate age-groups within the 20-79 year range. Self-report or registry data were used if blood glucose assessment was not available. The world prevalence of diabetes among adults (aged 20-79 years) will be 6.4%, affecting 285 million adults, in 2010, and will increase to 7.7%, and 439 million adults by 2030. Between 2010 and 2030, there will be a 69% increase in numbers of adults with diabetes in developing countries and a 20% increase in developed countries. These predictions, based on a larger number of studies than previous estimates, indicate a growing burden of diabetes, particularly in developing countries. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global estimates of diabetes prevalence for 2013 and projections for 2035.

              Diabetes is a serious and increasing global health burden and estimates of prevalence are essential for appropriate allocation of resources and monitoring of trends. We conducted a literature search of studies reporting the age-specific prevalence for diabetes and used the Analytic Hierarchy Process to systematically select studies to generate estimates for 219 countries and territories. Estimates for countries without available source data were modelled from pooled estimates of countries that were similar in regard to geography, ethnicity, and economic development. Logistic regression was applied to generate smoothed age-specific prevalence estimates for adults 20-79 years which were then applied to population estimates for 2013 and 2035. A total of 744 data sources were considered and 174 included, representing 130 countries. In 2013, 382 million people had diabetes; this number is expected to rise to 592 million by 2035. Most people with diabetes live in low- and middle-income countries and these will experience the greatest increase in cases of diabetes over the next 22 years. The new estimates of diabetes in adults confirm the large burden of diabetes, especially in developing countries. Estimates will be updated annually including the most recent, high-quality data available. Copyright © 2013. Published by Elsevier Ireland Ltd.
                Bookmark

                Author and article information

                Journal
                Antioxidants (Basel)
                Antioxidants (Basel)
                antioxidants
                Antioxidants
                MDPI
                2076-3921
                10 June 2019
                June 2019
                : 8
                : 6
                : 170
                Affiliations
                [1 ]Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China; mengjm@ 123456mail2.sysu.edu.cn (J.-M.M.); caoshy3@ 123456mail2.sysu.edu.cn (S.-Y.C.); xuxy53@ 123456mail2.sysu.edu.cn (X.-Y.X.)
                [2 ]Department of Food Science & Technology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China; weixinlin@ 123456sjtu.edu.cn
                [3 ]College of Life Sciences, Shanghai Normal University, 100 Guilin Road, Shanghai 200234, China; yfwang@ 123456shnu.edu.cn
                [4 ]Key Laboratory of Ministry of Education for Tea Science, Hunan Agricultural University, Changsha 410128, China; caishuxian@ 123456hunau.edu.cn
                [5 ]School of Agriculture and Food, The University of Melbourne, Parkville, Victoria 3010, Australia; pangzhen.zhang@ 123456unimelb.edu.au
                Author notes
                [* ]Correspondence: renyougan@ 123456sjtu.edu.cn (R.-Y.G.); lihuabin@ 123456mail.sysu.edu.cn (H.-B.L.); Tel.: +86-21-3420-8517 (R.-Y.G.); +86-20-8733-2391 (H.-B.L.)
                Author information
                https://orcid.org/0000-0002-4162-1511
                https://orcid.org/0000-0002-9794-2269
                https://orcid.org/0000-0003-2332-8554
                Article
                antioxidants-08-00170
                10.3390/antiox8060170
                6617012
                31185622
                db40b2d7-791e-4787-9210-839d049cc375
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 14 May 2019
                : 06 June 2019
                Categories
                Review

                tea,polyphenol,epigallocatechin-3-gallate,diabetes mellitus,complication,mechanisms

                Comments

                Comment on this article